ANDA 211227, held by Torrent. Eslicarbazepine Acetate.
As of Nov 16, 2026, ANDA 211227 (Eslicarbazepine Acetate), held by Torrent, was first approved by FDA on Feb 27, 2024, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 27, 2024 | Original application | Approved | None posted |
| Eslicarbazepine Acetate200MG · tablet;oral | Eslicarbazepine Acetate | Rx |
| Eslicarbazepine Acetate400MG · tablet;oral | Eslicarbazepine Acetate | Rx |
| Eslicarbazepine Acetate600MG · tablet;oral | Eslicarbazepine Acetate | Rx |
| Eslicarbazepine Acetate800MG · tablet;oral | Eslicarbazepine Acetate | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters